View from the Thoraxcenter: AHA 24 Late-breaking Preview

Average (ratings)
No ratings
 
  Your rating

Explore the cardiovascular breakthroughs shaping AHA 2024!

Join renowned experts Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) as they preview the most impactful late-breaking studies poised to make waves at this year’s AHA Conference. Dive into their expert analysis and gain key insights into the studies that are set to drive the future of cardiovascular care.

 

Trials discussed in detail include:
CLEAR-SYNERGY (01:01 - 03:45)
SELECT (03:45 - 04:47)
SUMMIT (04:47 - 08:28)
YELLOW III (08:28 - 11:05)
AMULET IDE (11:05 - 12:25)
VALOR-HCM (12:25 - 13:39)

Stay tuned for Radcliffe Cardiology's in-depth coverage of these and other pivotal trials from AHA Conference 2024.


Read MoreRead Less
Share
Ep 8: The Role of CT Coronary Angiography in Chronic Total Occlusion Intervention
EP17 • Sep 30, 2022 • 23m 47s
What considerations must be made when screening chronic total occlusion patients undergoing PCI, and how can CT be used in daily practice?

In this month's episode of ECR Podcast, Dr Vinoda Sharma, (Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK) and Dr Abdul Mozid, (Leeds Teaching Hospitals NHS Trust, Leeds, UK) discuss the ways in which CT coronary angiography can be utilised in chronic total occlusion percutaneous coronary interventions, and how the procedures differ across their UK-based practices.
Read More
Ep 7: Socioeconomic Factors Impacting Coronary and Structural Intervention
EP16 • Sep 12, 2022 • 26m 25s
What are the social factors that impact access to coronary and structural intervention in the current landscape of cardiology? In this month's episode of ECR Podcast, guest editor of ECR's special focus on gender disparities in interventional and structural heart procedures, Dr Natalia Berry (Mid Atlantic Permanente Medical Group, Washington DC, USA) is joined by Dr Renee Bullock-Palmer, (Deborah Heart and Lung Center, Pemberton, NJ, USA) to answer some of these questions.
Read More
Ep 6: Inflammatory Biomarkers and Cardiovascular Risk
EP15 • Jun 29, 2022 • 28m 46s
What are the clinical challenges in the use of biomarkers to estimate the risk of a cardiovascular event?
Read More
Targeting Inflammation in Atherosclerosis: Current Guidelines and Clinical Data
EP14 • May 16, 2022 • 7m 25s
Join Prof Juan Carlos Kaski (St George’s University of London, UK) and Dr Aernoud Fiolet (University Medical Center Utrecht, Netherlands) as they explore topics such as how guidelines currently view anti-inflammatory approaches and main molecules under investigation.

Supported by an unrestricted educational grant from NOVO NORDISK A/S.
Read More
Targeting Inflammation in Atherosclerosis: Inflammation and Atherosclerosis
EP13 • May 13, 2022 • 8m 39s
Inflammation and Atherosclerosis – What is the Link with CKD? Join Prof Juan Carlos Kaski (St George’s University of London, UK) and Prof Lina Badimon (Hospital of Santa Creu and San Pau, Barcelona, Spain) as they discuss that very question.
Read More
Targeting Inflammation in Atherosclerosis: Therapeutic Targets and Mode of Action
EP12 • May 16, 2022 • 6m 42s
Prof Juan Carlos Kaski (St George’s University of London, UK) alongside Dr Peter Libby (Brigham and Women’s Hospital, Boston, US) provide us with a short and concise discussion regarding Therapeutic Targets and Mode of Action.
Read More
Targeting Inflammation in Atherosclerosis: Inflammatory Signalling in Atherosclerosis and CKD
EP11 • May 13, 2022 • 8m 36s
Inflammatory Signalling in Atherosclerosis and CKD is the topic of interest in this short peer to peer discussion involving Prof Juan Carlos Kaski (St George’s University of London, UK) and Prof Paul Ridker (Brigham and Women’s Hospital, Boston, US).

Supported by an unrestricted educational grant from NOVO NORDISK A/S.
Read More
Targeting Inflammation in Atherosclerosis: Unmet Clinical Needs in Atherosclerosis and Chronic Kidney Disease
EP10 • May 13, 2022 • 9m 50s
Prof Juan Carlos Kaski (St George’s University of London, UK) is joined by Prof Paul Ridker (Brigham and Women’s Hospital, Boston, US) to discuss Unmet Clinical Needs in Atherosclerosis and Chronic Kidney Disease where they cover topics such as elevated hsCRP and chronic kidney disease.
Read More
Targeting Inflammation in Atherosclerosis: COLCOT Trial
EP9 • Apr 22, 2022 • 5m 13s
Prof Jean-Claude Tardif (Montreal Heart Institute, Canada) gives us a comprehensive overview of the COLCOT trial.
Read More
Targeting Inflammation in Atherosclerosis: LoDoCo2 Trial
EP8 • Apr 22, 2022 • 5m 3s
In this LoDoCo2 presentation, Dr Aernoud Fiolet (University Medical Center Utrecht, Netherlands) covers the trial design and main results.

Supported by an unrestricted educational grant from NOVO NORDISK A/S.

Read More
Targeting Inflammation in Atherosclerosis: RESCUE Trial
EP7 • Apr 12, 2022 • 4m 22s
Join Dr Peter Libby (Brigham and Women’s Hospital, Boston, US) as he talks us through the RESCUE trial design and results in this short podcast.
Read More
Targeting Inflammation in Atherosclerosis: CANTOS Trial
EP6 • Apr 12, 2022 • 6m 19s
Prof Paul Ridker (Brigham and Women’s Hospital, Boston, US) provides us with an overview of the CANTOS main trial results and updated results from the ACC 2022.
Read More
Ep 5: Invasive Diagnosis of Coronary Functional Disorder
EP5 • Mar 25, 2022 • 29m 28s
Did you know that coronary vasomotion disorders are a frequent cause of angina in patients with non-obstructed coronary arteries? In this month's episode of the ECR podcast, Dr Andreas Seitz and Dr Peter Ong (Robert-Bosch Hospital, Stuttgart, DE) return to discuss their recent article on the diagnosis of coronary disorders which cause angina (https://www.ecrjournal.com/articles/invasive-diagnosis-coronary-functional-disorders-causing-angina-pectoris) from ECR Journal.
Read More
Ep 4: The EXCEL Trial: The Interventionalists’ Perspective
EP4 • Jan 28, 2022 • 12m 40s
In this month's featured author episode of the ECR Podcast, interventional fellow Dr George Hunter (Bedfordshire Hospitals NHS Foundation Trust, Bedford, UK) discusses the EXCEL trial from his perspective as a member of the PCI community, based on a recent review paper from the ECR Journal. In this podcast, Dr Hunter discusses the controversy surrounding the trial and the importance of studying left main stem disease in cardiology today.
Read More
Ep 3: Atrial Fibrillation in Congenital Heart Disease
EP3 • Nov 30, 2021 • 16m 52s
Did you know that atrial arrhythmias are the most common complication in adults with congenital heart disease?

Dr Irene Martin de Miguel (Hospital General Universitario Gregorio Marañón, Madrid, Spain) joins us in this featured author episode to outline her recent review article, Atrial Fibrillation in Congenital Heart Disease. In this podcast, Dr de Miguel provides an overview of the current knowledge of AF in CHD, giving practical recommendations for your everyday practice.
Read More